62 related articles for article (PubMed ID: 1721257)
21. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
22. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
23. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
24. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
25. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch T; Hohman RJ
Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
[No Abstract] [Full Text] [Related]
26. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
[No Abstract] [Full Text] [Related]
27. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
[No Abstract] [Full Text] [Related]
28. Immunosuppressive macrolides.
Stütz A
Transplant Proc; 1992 Aug; 24(4 Suppl 2):22-5. PubMed ID: 1379762
[No Abstract] [Full Text] [Related]
29. Immunosuppressive agents: recent developments in molecular action and clinical application.
Gerber DA; Bonham CA; Thomson AW
Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
[No Abstract] [Full Text] [Related]
30. Cyclosporine, FK-506 and other drugs in organ transplantation.
Morris PJ
Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
[TBL] [Abstract][Full Text] [Related]
31. Immunopharmacology of new xenobiotic immunosuppressive molecules.
Morris RE
Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
[No Abstract] [Full Text] [Related]
32. The antimicrobial activities of cyclosporine, FK506, and rapamycin.
High KP
Transplantation; 1994 Jun; 57(12):1689-700. PubMed ID: 7517076
[No Abstract] [Full Text] [Related]
33. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
34. Molecular immunology and immunopharmacology of allograft rejection.
Strom TB
Kidney Int Suppl; 1992 Oct; 38():S182-7. PubMed ID: 1383599
[No Abstract] [Full Text] [Related]
35. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
Siekierka JJ
Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
[TBL] [Abstract][Full Text] [Related]
36. The immunosuppressive macrolides FK-506 and rapamycin.
Thomson AW
Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive approaches to the prevention of graft vascular disease.
Gregory CR
Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
[No Abstract] [Full Text] [Related]
38. Immunosuppressive drugs and the induction of transplantation tolerance.
Thomson AW
Transpl Immunol; 1994 Dec; 2(4):263-70. PubMed ID: 7535641
[No Abstract] [Full Text] [Related]
39. The spectrum of action of new immunosuppressive drugs.
Thomson AW
Clin Exp Immunol; 1992 Aug; 89(2):170-3. PubMed ID: 1379130
[No Abstract] [Full Text] [Related]
40. Cyclosporine, FK-506, rapamycin, and other immunomodulators.
Yocum DE
Rheum Dis Clin North Am; 1996 Feb; 22(1):133-54. PubMed ID: 8907069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
